期刊名称：NUCLEAR MEDICINE AND BIOLOGY
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
Nuclear Medicine and Biology
|
Nuclear Medicine and Biology publishes original research covering all aspects of radiopharmaceutical chemistry: synthesis, radiopharmacy, in vitro and ex vivo testing, and in vivo evaluation of molecular probes for PET,SPECT, planar imaging, and autoradiography. These multidisciplinary studies should demonstrate the mechanism of localization whether the radioactive substance is based on receptor, enzyme, tumor antigen, or other well-defined biochemistry. The study should also address the sensitivity of the probe to changes in |
 |
|
biochemistry, although studies of mechanism alone are acceptable. Contributions on the subject of therapeutic radiopharmaceuticals also are appropriate provided that the specificity of labeled compound localization and therapeutic effect have been addressed. If the synthesis of a new radiopharmaceutical is submitted alone, then the uniqueness of the chemistry must be emphasized. Papers that describe instrumentation important to molecular imaging as well as papers describing translational clinical research and the issues of extending preclinical research to clinical studies are also welcome. | Abstracting / Indexing
- Applied Health Physiology Abstracts
- BIOSIS
- Cambridge Scientific Abstracts
- Chemical Abstracts
- Current Contents ISI/Biomed Data
- Current Contents/Life Sciences
- Current Contents/SciSearch Database
|
- EMBASE
- Elsevier BIOBASE
- Health and Safety Science Abstracts
- Index Medicus
- Medline
- Research Alert
- Toxicology Abstracts
|
Instructions to Authors
Manuscripts should be submitted directly to the Editor-in-Chief and not to the publisher's office. English is the language of choice.
Authors can submit PDF files to the Editor-in-Chief at wceckelman@comcast.net. E-mail attachments should not exceed 5 MB; a single PDF file should include text and all figures.
Style
Manuscripts must be typewritten and double-spaced. One double-spaced typewritten original and two copies should be submitted. The first page should include:
(a) the title, which should be concise but informative.
(b) an abbreviated title of not more than 45 letters and spaces for abstracting and indexing purposes.
(c) the authors' names and institutions including postal address in full for the corresponding author.
(d) the author to whom correspondence should be sent, including telephone and FAX numbers, and e-mail address, if available.
(e) for indexing purposes, please provide up to 6 key words.
An abstract of not more than 80 words must be supplied for all articles, and preferably a short summary for Technical Notes.
Animal experiments
In manuscripts describing experiments with living animals, authors should state clearly in the text that the experiments were carried out in compliance with the relevant national laws relating to the conduct of animal experimentation, or, where such laws do not exist, that the studies were performed in accordance with some internationally recognized code of practice such as the United Kingdom Biological Council's Guidelines on the Use of Living Animals in Scientific Investigations, 2nd edn.
Illustrations and Tables (see below) should not be placed in the body of the text, but their approximate location should be indicated in the margin. All figure captions must be typed in a list on a separate sheet at the end of the script.
Nomenclature
Preferably Systeme International (SI) units should be used throughout with equivalent quantities in older usage indicated in parentheses. NBS Special Publication 330 The International System of Units (SI) or the Systeme International d'Unites may be helpful in this respect. Chemical and biological nomenclature should conform to International Union of Pure and Applied Chemistry (IUPAC) recommendations. The IUPAC Rules can be found in the Handbook of Chemistry and Physics, CRC Press Inc., Boca Raton, Fla. Radioactive labels should be indicated by the radionuclide's symbol in square brackets before the labeled compound, e.g. [3H]H2O, [14C]carbon dioxide, 2-amino-4-([11C]methylthio) butyric acid (not 11C]methyl-methionine), N-[11C]methyl-normorphine, etc. Carrier-free compounds only should be designated as 3H2O, 13NH3, etc. No-carrier-added compounds should be written as [13N]NH3, [11C]CO2 unless proof of specific activity is given. Metastable (isomeric) and ground state of nuclei are designated by an "m" or "g" respectively, placed after the atomic-mass number, e.g. 99mTc and 99gTc although the "g" may be omitted if no ambiguity results.
References
Text: Indicate references by number(s), in square brackets in line with the text. The actual authors can be referred to, but the reference number(s) must always be given.
List: Number the references (numbers in square brackets) in the order in which they appear in the text.
Reference to a journal publication:
[1] Van der Geer J, Hanraads JAJ, Lupton RA. The art of writing a scientific article. J Sci Commun 2000:163:51-9.
Reference to a book:
[2] Strunk Jr W, White EB. The elements of style. 3rd ed. New York: Macmillan, 1979.
Reference to a chapter in an edited book:
[3] Mettam GR, Adams LB. How to prepare an electronic version of your article. In: Jones BS, Smith TX, editors. Introduction to the electronic age. New York: E-Publishing Inc.; 1999, p. 281-304.
Computer Disks
Authors are encouraged to submit a 3.5" HD/DD computer disk to the editorial office; 5.25" HD/DD disks are acceptable if 3.5" disks are unavailable. Please observe the following criteria: 1. Send only hard copy when first submitting your paper. 2. When your paper has been refereed, revised if necessary, and accepted, send a disk containing the final version with the final hard copy. Make sure that the disk and the hardcopy match exactly (otherwise the diskette version will prevail). 3. Specify what software was used, including which release, e.g., WordPerfect 6.0a. 4. Specify what computer was used (IBM-compatible PC, Apple Macintosh, etc.). 5. The article file should include all textual material (text, references, tables, figure captions, etc.) and separate illustration files, if available. 6. The file should follow the general instructions on style/arrangement and, in particular, the reference style of this journal as given in the Instructions to Contributors.7. The file should be single-spaced and use the wrap-around end-of-line feature, i.e., returns at the end of paragraphs only. Place two returns after every element such as title, headings, paragraphs, figure and table call-outs. 8. Keep a backup disk for reference and safety.
Illustrations
One copy of the original and two photocopies should be supplied. They must be clearly identified by number and by authors' names by labels on the back of the illustrations as they will be handled separately from the captions and from the rest of the manuscript.
Tables
Each table should be typed, with caption, on a separate sheet at the end of the manuscript.
Extensive tables should be suitable for direct photographic reproduction, and thus are to be treated as illustrations (see above).
Proofs
Proofs will be despatched to the first-named author, unless otherwise requested. They should be returned with the least possible delay. Corrections to the proofs must be restricted to printer's errors only. Any substantial changes other than these will be charged to the author. Please note that authors are urged to check their proofs carefully before return, since late corrections cannot be guaranteed for inclusion in the printed journal.
Offprints
Offprints and copies of the issue (at a specially reduced rate) can be ordered on the offprint order form that will accompany the proofs. This should be returned together with the corrected proofs and any outstanding Transfer of Copyright forms to: Reprints Department, Elsevier Inc., 360 Park Avenue South, New York, NY 10010-1710, USA; Tel: (212)462-1954; Fax: (212)462-1955.
Return of manuscript
Authors of accepted papers requiring the return of their manuscript or original material should make their request known as soon as possible, as they will normally be discarded one month after publication.
Editorial Board
Editor-in-Chief:
William C. Eckelman, National Institutes of Health, Bethesda, MD, USA; Fax: 301-564-3022,
Email: wceckelman@comcast.net
Editors:
J.R. Barrio, UCLA School of Medicine, Los Angeles, CA, USA
E.W. Bradley, National Institutes of Health, Bethesda, MD, USA
M.W. Brechbiel, National Insitutes of Health, Bethesda, MD, USA
H.H. Coenen, Forschungszentrum J¨¹lich GmbH, J¨¹lich, Germany
Y. Fujibayashi, Fukui Medical University, Fukui, Japan
C. Halldin, Karolinska Institute, Stockholm, Sweden
G.D. Hutchins, Indiana University School of Medicine, Indianapolis, IN, USA
B. Johannsen, Rossendorf Institut f¨¹r Bioanorganische und Radiopharmazeutische Chemie, Dresden, Germany
A.G. Jones, Harvard Medical School, Boston, MA, USA
S.S. Jurisson, University of Missouri, Columbia, MO, USA
M.R. Kilbourn, University of Michigan Medical School, Ann Arbor, MI, USA
L. Knight, Temple University, Philadelphia, PA, USA
D.A. Mankoff, University of Washington Medical Center, Seattle, WA, USA
C.A. Mathis, Presbyterian University Hospital, Pittsburgh, PA, USA
C. Paik, National Institutes of Health, Bethesda, MD, USA
B.E. Rogers, University of Alabama at Birmingham, Birmingham, AL, USA
R.P. Spencer, University of Connecticut Health Center, Farmington, CT, USA
M.L. Thakur, Thomas Jefferson University, Philadelphia, PA, USA
H.F. VanBrocklin, Lawrence Berkeley Labs, Berkeley, CA, USA
D. Vera, University of California San Diego Medical Center, San Diego, CA, USA
W.A. Volkert, H.S. Truman Memorial VA Medical Center, Columbia, MO, USA
H.N. Wagner, Jr., Johns Hopkins Medical Institution, Baltimore, MD, USA
A. Yokoyama, Kyoto University, Kyoto, Japan
M.R. Zalutsky, Duke University Medical Center, Durham, NC, USA
B. Zimmerman, National Institute of Standards and Technology, Gaithersburg, MD, USA
Founder Editor:
J. Sternberg
|
